← Leaderboards
Eckhard K Ficker
Metrohealth Medical Center
$1,893,369
Attributed
$1,893,369
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $337.5K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$1,893,369 · 2
By mechanism
R01$1,644,594 · 1
R43$248,775 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Protein Degradation”
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Jeffery W Kelly · Scripps Research Institute$26,820,426
- Alexander J Varshavsky · California Institute Of Technology$26,534,363
- Rama K Mallampalli · Ohio State University$24,781,659
- Larry Arthur$22,516,306
- Robert T Sauer · Massachusetts Institute Of Technology$22,030,267
Research focus
Protein DegradationGene MutationVoltage /Patch ClampEndoplasmic ReticulumLong Qt SyndromeMolecular ChaperonesPotassium ChannelUbiquitinImmunoprecipitationBiogenesisCell MembraneElectrophysiology (Science)Chaperone GeneChaperone MachineryAction PotentialsInheritedGene TransferCardiacDominant-Negative MutationHeartAutoradiographyGenesDefectEther, Ethyl
Grant awards (6)
Role of Molecular Chaperones in hERG Processing$320,012
R01 · FY2008 · HL · contact PI
Role of Molecular Chaperones in hERG Processing$320,012
R01 · FY2007 · HL · contact PI
Role of Molecular Chaperones in hERG Processing$329,570
R01 · FY2006 · HL · contact PI
Role of Molecular Chaperones in hERG Processing$337,500
R01 · FY2005 · HL
Role of Molecular Chaperones in hERG Processing$337,500
R01 · FY2004 · HL
A High Throughput Assay for Cancer Drug Cardiotoxicity$248,775
R43 · FY2004 · CA